BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25209396)

  • 1. Liposomal bladder instillations for IC/BPS: an open-label clinical evaluation.
    Peters KM; Hasenau D; Killinger KA; Chancellor MB; Anthony M; Kaufman J
    Int Urol Nephrol; 2014 Dec; 46(12):2291-5. PubMed ID: 25209396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.
    Chuang YC; Kuo HC
    J Urol; 2017 Aug; 198(2):376-382. PubMed ID: 28202358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome.
    Peng YC; Yueh-Hsia Chiu S; Feng M; Liang CC
    Taiwan J Obstet Gynecol; 2020 Nov; 59(6):922-926. PubMed ID: 33218413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and dose flexibility clinical evaluation of intravesical liposome in patients with interstitial cystitis or painful bladder syndrome.
    Lee WC; Chuang YC; Lee WC; Chiang PH
    Kaohsiung J Med Sci; 2011 Oct; 27(10):437-40. PubMed ID: 21943815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.
    Lee CL; Kuo HC
    Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second multicenter, randomized, double-blind, parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome.
    Nickel JC; Hanno P; Kumar K; Thomas H
    Urology; 2012 Jun; 79(6):1220-4. PubMed ID: 22516357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid improves pain symptoms more than bladder storage symptoms in women with interstitial cystitis.
    Hung MJ; Tsai CP; Lin YH; Huang WC; Chen GD; Shen PS
    Taiwan J Obstet Gynecol; 2019 May; 58(3):417-422. PubMed ID: 31122535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome.
    Kuo HC
    Int J Clin Pract; 2013 May; 67(5):427-34. PubMed ID: 23574103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open Label, Pilot Evaluation of the Safety and Efficacy of Intravesical Sustained Release System of Lidocaine and Oxybutynin (TRG-100) for Patients With Interstitial Cystitis/Bladder Pain Syndrome, Overactive Bladder and Patients With Retained Ureteral Stents Following Endourological Interventions.
    Raisin G; Dothan D; Perez D; Ala-Adin N; Kafka I; Shenfeld O; Hatumi S; Malchi N; Gordon A; Touitou D; Moldwin R; Nassar T; Chertin B
    Urology; 2023 Aug; 178():42-47. PubMed ID: 37268171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome.
    Chuang YC; Lee WC; Lee WC; Chiang PH
    J Urol; 2009 Oct; 182(4):1393-400. PubMed ID: 19683290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in sexual function of women with refractory interstitial cystitis/bladder pain syndrome after intravesical therapy with a hyaluronic acid solution.
    Hung MJ; Su TH; Lin YH; Huang WC; Lin TY; Hsu CS; Chuang FC; Tsai CP; Shen PS; Chen GD
    J Sex Med; 2014 Sep; 11(9):2256-63. PubMed ID: 24636240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary and psychological outcomes in women with interstitial cystitis/bladder pain syndrome following hyaluronic acid treatment.
    Liang CC; Lin YH; Hsieh WC; Huang L
    Taiwan J Obstet Gynecol; 2018 Jun; 57(3):360-363. PubMed ID: 29880165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety comparison of pharmacotherapies for interstitial cystitis and bladder pain syndrome: a systematic review and Bayesian network meta-analysis.
    Di XP; Luo DY; Jin X; Zhao WY; Li H; Wang KJ
    Int Urogynecol J; 2021 May; 32(5):1129-1141. PubMed ID: 33638677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Clinical Efficacy and Adverse Events between Intravesical Injections of Platelet-Rich Plasma and Botulinum Toxin A for the Treatment of Interstitial Cystitis Refractory to Conventional Treatment.
    Jhang JF; Yu WR; Kuo HC
    Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability and validity of Turkish versions of the interstitial cystitis symptom index and interstitial cystitis problem index.
    Esen B; Obaid K; Süer E; Gökçe Mİ; Gökmen D; Bedük Y; Gülpınar Ö
    Neurourol Urodyn; 2020 Nov; 39(8):2338-2343. PubMed ID: 32846036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Feasibility of Intravesical Instillation of Botulinum Toxin-A in Hydrogel-based Slow-release Delivery System in Patients With Interstitial Cystitis-Bladder Pain Syndrome: A Pilot Study.
    Rappaport YH; Zisman A; Jeshurun-Gutshtat M; Gerassi T; Hakim G; Vinshtok Y; Stav K
    Urology; 2018 Apr; 114():60-65. PubMed ID: 29307733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of onabotulinum toxin-A injection on sexual function in women with refractory interstitial cystitis/bladder pain syndrome: A prospective study.
    Karaburun MC; Kubilay E; Öztuna D; Gökçe Mİ; Süer E; Gülpınar Ö
    Low Urin Tract Symptoms; 2024 Mar; 16(2):e12511. PubMed ID: 38527461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O'Leary-Sant Symptom Index Predicts the Treatment Outcome for OnabotulinumtoxinA Injections for Refractory Interstitial Cystitis/Bladder Pain Syndrome.
    Kuo YC; Kuo HC
    Toxins (Basel); 2015 Jul; 7(8):2860-71. PubMed ID: 26264022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical comparison of intravesical hyaluronic acid and chondroitin sulfate therapies in the treatment of bladder pain syndrome/interstitial cystitis.
    Gülpınar Ö; Esen B; Kayış A; Gökçe Mİ; Süer E
    Neurourol Urodyn; 2018 Jan; 37(1):257-262. PubMed ID: 28480984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of intravesical instillation with fulguration-hydrodistention on female interstitial cystitis].
    Xin P; Zhang H; Jiang ZM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 55(5):865-870. PubMed ID: 37807741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.